
Results
2
2 companies
MedinCell
Market Cap: €879.8m
Engages in the research and development of biodegradable polymer-based processes for the controlled and prolonged delivery of active pharmaceutical ingredients into the human body and animals in France.
MEDCL
€24.46
7D
0.08%
1Y
37.4%
DBV Technologies
Market Cap: €760.5m
A clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France.
DBV
€2.54
7D
4.1%
1Y
48.4%